Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Birgit, Stadlbauer"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundManagement of clear cell renal cell carcinoma (ccRCC) has changed rapidly in recent years with the advent of immune checkpoint inhibitors (ICIs). However, only a limited number of patients can sustainably respond to immune checkpoint inhibi
Externí odkaz:
https://doaj.org/article/16117f6c21bf4419a463007448fdf294
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15955
Emerging evidence from research or clinical studies reported that ABCG2 (ATP-binding cassette sub-family G member 2) interrelates with multidrug resistance (MDR) development in cancers. However, no comprehensive pan-cancer analysis is available at pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ebf880b9275d7c4fa9e5a28de97570
https://pubmed.ncbi.nlm.nih.gov/36555598
https://pubmed.ncbi.nlm.nih.gov/36555598
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4200
Cancers 14:4200 (2022)
Cancers 14:4200 (2022)
The aim of the study was to develop a new therapeutic strategy to target cancer stem cells (CSCs) in clear cell renal cell carcinoma (ccRCC) and to identify typical CSC markers to improve therapy effectiveness. It was found that the corrected-mRNA ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9cd0b58df5b27d28fd143378a68b5b
Autor:
Maxim Werner, Chen Lyu, Birgit Stadlbauer, Isabel Schrader, Alexander Buchner, Herbert Stepp, Ronald Sroka, Heike Pohla
Publikováno v:
Photodiagnosis and Photodynamic Therapy. 39:102987
Glioblastoma multiforme is a malignant neoplasia with a median survival of less than two years and without satisfactory therapeutic options. The so-called glioblastoma stem cells escape the established radio- and chemotherapies and lead to tumor recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0795e49d0862dd4c6be985a7123bfb2a
https://doi.org/10.1016/j.pdpdt.2022.102987
https://doi.org/10.1016/j.pdpdt.2022.102987
Publikováno v:
Am J Cancer Res
Cancer stem cells (CSCs) are a small population among cancer cells, defined as capable of self-renewal, and driving tumor growth, metastasis, and therapeutic relapse. The development of therapeutic strategies to target CSCs is of great importance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::682bc4f4860ef26d43448f0da91e91f9
https://pubmed.ncbi.nlm.nih.gov/33294267
https://pubmed.ncbi.nlm.nih.gov/33294267
Background: Cancer stem cells (CSCs) are a small population among cancer cells, defined as capable of self-renewal, and driving tumor growth, metastasis, and therapeutic relapse. The development of therapeutic strategies to target CSCs is of great im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c6abe1d66e63ec0fb61cd7ae8264359
https://doi.org/10.21203/rs.3.rs-58823/v1
https://doi.org/10.21203/rs.3.rs-58823/v1
Publikováno v:
Journal of Urology. 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c743643673a244e1b6c26f3b52f4a6a7
https://doi.org/10.1016/j.juro.2018.02.2296
https://doi.org/10.1016/j.juro.2018.02.2296
Publikováno v:
Journal of Urology. 197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c73fa4347c3a9d851f795b10def5848a
https://doi.org/10.1016/j.juro.2017.02.2587
https://doi.org/10.1016/j.juro.2017.02.2587
Autor:
Dolores J. Schendel, Birgit Stadlbauer, B Dörken, Gerald Willimsky, Ralph Oberneder, Bernhard Frankenberger, Alfons Hofstetter, Heike Pohla, Antonio Pezzutto, Thomas Blankenstein
Publikováno v:
Bone Marrow Transplantation. 25:S83-S87
An allogeneic tumor cell vaccine should display a natural immunogenicity that allows the stimulation of tumor-reactive effector cells in patients. Furthermore, the vaccine should express antigens that are shared by many tumors to which patients are n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c03969b3a1b16e7afdcc44ef6159df
https://doi.org/10.1038/sj.bmt.1702362
https://doi.org/10.1038/sj.bmt.1702362
Autor:
Claudia J. Dembek, Volker Erfle, Giuseppe Tambussi, Priscilla Biswas, Paolo Lusso, Simone Allgayer, Heike Pohla, Hans Jürgen Stellbrink, Frank D. Goebel, Marco Tinelli, Johannes R. Bogner, Antonio Cosma, Guido Poli, Sarah Kutscher, Birgit Stadlbauer, Silvia Heltai, Mauro S. Malnati, Silvia Nozza
Publikováno v:
Aids Res. Ther. 5:22 (2008)
AIDS Research and Therapy
AIDS Research and Therapy, Vol 5, Iss 1, p 22 (2008)
AIDS Research and Therapy
AIDS Research and Therapy, Vol 5, Iss 1, p 22 (2008)
Background T-cell mediated immunity likely plays an important role in controlling HIV-1 infection and progression to AIDS. Several candidate vaccines against HIV-1 aim at stimulating cellular immune responses, either alone or together with the induct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577bcf6bc685445c7452c81d7beda7aa
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=546
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=546